Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer. | Medicine (Baltimore) | 2022 | 35119046 | PubTator, text mining | PubMed |
| Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database. | BMC Cancer | 2022 | 35114976 | PubTator, text mining | PubMed |
| Germline Variants in DNA Damage Repair Genes: An Emerging Role in the Era of Precision Medicine in Pancreatic Adenocarcinoma. | Ann Gastroenterol Surg | 2022 | 35106410 | PubTator, text mining | PubMed |
| Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. | Cell Res | 2022 | 35105939 | PubTator, text mining | PubMed |
| Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer. | Clin Cancer Res | 2022 | 35101884 | PubTator, text mining | PubMed |
| Subtyping of sarcomas based on pathway enrichment scores in bulk and single cell transcriptomes. | J Transl Med | 2022 | 35093080 | PubTator, text mining | PubMed |
| Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma. | Adv Sci (Weinh) | 2022 | 35088582 | PubTator, text mining | PubMed |
| Dual-functional significance of ATM-mediated phosphorylation of spindle assembly checkpoint component Bub3 in mitosis and the DNA damage response. | J Biol Chem | 2022 | 35085551 | PubTator, text mining | PubMed |
| Modular assembly of the principal microtubule nucleator γ-TuRC. | Nat Commun | 2022 | 35078983 | PubTator, text mining | PubMed |
| BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B) promotes lung adenocarcinoma by interacting with Zinc Finger Protein ZNF143 and regulating glycolysis. | Bioengineered | 2022 | 35068350 | PubTator, text mining | PubMed |
| Anticancer Effects and Molecular Action of 7-α-Hydroxyfrullanolide in G2/M-Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cells. | Molecules | 2022 | 35056723 | PubTator, text mining | PubMed |
| Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer. | J Pers Med | 2022 | 35055380 | PubTator, text mining | PubMed |
| Biallelic BUB1 mutations cause microcephaly, developmental delay, and variable effects on cohesion and chromosome segregation. | Sci Adv | 2022 | 35044816 | PubTator, text mining | PubMed |
| Germline sequence variants contributing to cancer susceptibility in South African breast cancer patients of African ancestry. | Sci Rep | 2022 | 35039564 | PubTator, text mining | PubMed |
| Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer. | J Immunother Cancer | 2022 | 35039462 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response. | Ann Med | 2022 | 35037540 | PubTator, text mining | PubMed |
| Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis. | Cancer Cell Int | 2022 | 35033076 | PubTator, text mining | PubMed |
| The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | Nat Cell Biol | 2022 | 35013556 | PubTator, text mining | PubMed |
| LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma. | Genes Dis | 2022 | 35005115 | PubTator, text mining | PubMed |
| Orchestrating serine/threonine phosphorylation and elucidating downstream effects by short linear motifs. | Biochem J | 2022 | 34989786 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=44